PTEN aberrations have been found in 7%–80% of urothelial carcinoma of the bladder [19, 20] with some studies suggesting associations with advanced stage and grade, while others found no relationship to tumor phenotype [21, 22, 23, 24, 25, 26, 27, 28]. This evidence concerns the gene PTEN and neoplasm.